ARTICLES
Ki-1-positive anaplastic large-cell lymphoma: a clinicopathologic entity?
ME Kadin
JCO Apr 1 1991: 533–536. [PDF]
Radiolabeled antibodies: another form of cytotoxic treatment
R Levy and RA Miller
JCO Apr 1 1991: 537–538. [PDF]
	Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma
	JP Greer, MC Kinney, RD Collins, KE Salhany, SN Wolff, JD Hainsworth, JM Flexner, and RS Stein
	JCO Apr 1 1991: 539–547. [Abstract] [PDF]
	Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody
	DM Goldenberg, JA Horowitz, RM Sharkey, TC Hall, S Murthy, H Goldenberg, RE Lee, R Stein, JA Siegel, and DO Izon
	JCO Apr 1 1991: 548–564. [Abstract] [PDF]
	Phase II trial of pentostatin in refractory lymphomas and cutaneous T- cell disease
	FJ Cummings, K Kim, RS Neiman, RL Comis, MM Oken, SA Weitzman, RB Mann, and MJ O'Connell
	JCO Apr 1 1991: 565–571. [Abstract] [PDF]
	High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study
	Y Ravindranath, CP Steuber, J Krischer, CI Civin, J Ducore, R Vega, P Pitel, S Inoue, E Bleher, and C Sexauer
	JCO Apr 1 1991: 572–580. [Abstract] [PDF]
	Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study
	AT Look, FA Hayes, JJ Shuster, EC Douglass, RP Castleberry, LC Bowman, EI Smith, and GM Brodeur
	JCO Apr 1 1991: 581–591. [Abstract] [PDF]
	Quality of life in long-term survivors of CNS tumors of childhood and adolescence
	EN Mostow, J Byrne, RR Connelly, and JJ Mulvihill
	JCO Apr 1 1991: 592–599. [Abstract] [PDF]
	Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study
	AM Goorin, JJ Shuster, A Baker, ME Horowitz, WH Meyer, and MP Link
	JCO Apr 1 1991: 600–605. [Abstract] [PDF]
	A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin
	M Fukuoka, N Masuda, K Furuse, S Negoro, M Takada, K Matsui, N Takifuji, S Kudoh, M Kawahara, and M Ogawara
	JCO Apr 1 1991: 606–613. [Abstract] [PDF]
	Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients
	M Wolf, M Pritsch, P Drings, K Hans, M Schroeder, H Flechtner, M Heim, D Hruska, S Mende, and H Becker
	JCO Apr 1 1991: 614–624. [Abstract] [PDF]
	A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma
	B Ardalan, L Chua, EM Tian, R Reddy, K Sridhar, P Benedetto, S Richman, A Legaspi, S Waldman, and L Morrell
	JCO Apr 1 1991: 625–630. [Abstract] [PDF]
	Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer
	TW Griffin, AB Brill, S Stevens, JA Collins, F Bokhari, H Bushe, MC Stochl, M Gionet, M Rusckowski, and SD Stroupe
	JCO Apr 1 1991: 631–640. [Abstract] [PDF]
	A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma
	JP Dutcher, ER Gaynor, DH Boldt, JH Doroshow, MH Bar, M Sznol, J Mier, J Sparano, RI Fisher, and G Weiss
	JCO Apr 1 1991: 641–648. [Abstract] [PDF]
	A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinoma
	S Kirmani, WE Lucas, S Kim, R Goel, L McVey, J Morris, and SB Howell
	JCO Apr 1 1991: 649–657. [Abstract] [PDF]
	Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma
	PF Conte, M Bruzzone, F Carnino, S Chiara, M Donadio, V Facchini, P Fioretti, G Foglia, A Gadducci, and L Gallo
	JCO Apr 1 1991: 658–663. [Abstract] [PDF]
	Cisplatin and etoposide as first-line chemotherapy for metastatic breast carcinoma: a prospective randomized trial of the Italian Oncology Group for Clinical Research
	G Cocconi, G Bisagni, M Bacchi, C Boni, R Bartolucci, G Ceci, MA Colozza, V De Lisi, R Lottici, and AM Mosconi
	JCO Apr 1 1991: 664–669. [Abstract] [PDF]
	Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2
	PC Adamson, FM Balis, CL McCully, KS Godwin, JD Bacher, TJ Walsh, and DG Poplack
	JCO Apr 1 1991: 670–674. [Abstract] [PDF]
	Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone
	F Roila, M Tonato, F Cognetti, E Cortesi, G Favalli, M Marangolo, D Amadori, MA Bella, V Gramazio, and D Donati
	JCO Apr 1 1991: 675–678. [Abstract] [PDF]
	Cytarabine and neurologic toxicity
	WJ Baker, GL Royer, Jr, and RB Weiss
	JCO Apr 1 1991: 679–693. [Abstract] [PDF]
	Interleukin-2 toxicity
	JP Siegel and RK Puri
	JCO Apr 1 1991: 694–704. [Abstract] [PDF]
Half-body irradiation in multiple myeloma
JS Tobias, NP Rowell, and JD Richards
JCO Apr 1 1991: 705–707. [PDF]
Cisplatin nephrotoxicity: diethyldithiocarbamate, WR2721, or just water?
E Cvitkovic, DM Hayes, RB Golbey, and IH Krakoff
JCO Apr 1 1991: 707–709. [PDF]
Testis cancer: a model for other solid tumors?
MS Blumenreich
JCO Apr 1 1991: 709. [PDF]

SPECIAL DEPARTMENTS
ERRATUM
	Superiority of ProMACE-CytaBOM Over ProMACE-MOPP in the Treatment of Advanced Diffuse Aggressive Lymphoma: Results of a Prospective Randomized Trial
	Dan L. Longo, Vincent T. DeVita, Jr, Patricia L. Duffey, Margaret N. Wesley, Daniel C. Ihde, Susan M. Hubbard, Mercedes Gilliom, Elaine S. Jaffe, Jeffrey Cossman, Richard I. Fisher, and Robert C. Young
	JCO Apr 1 1991: 710. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.